Global Artemisinin Combination Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Artemisinin Combination Therapy Market Overview

• 1.1 Product Overview and Scope of Artemisinin Combination Therapy
• 1.2 Classification of Artemisinin Combination Therapy by Types
  • 1.2.1 Global Artemisinin Combination Therapy Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Artemisinin Combination Therapy Revenue Market Share by Types in 2018
  • 1.2.3 Artemether+Lumefantrine
  • 1.2.4 Artesunate+Amodiaquine
  • 1.2.5 Dihydroartemisinin+Piperaquine
  • 1.2.6 Artesunate+Mefloquine
  • 1.2.7 Artesunate+Sulfadoxine-Pyrimethamine
  • 1.2.8 Pyronaridine-Artesunate
  • 1.2.9 Other
• 1.3 Global Artemisinin Combination Therapy Market by Application
  • 1.3.1 Global Artemisinin Combination Therapy Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Other
• 1.4 Global Artemisinin Combination Therapy Market by Regions
  • 1.4.1 Global Artemisinin Combination Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Artemisinin Combination Therapy Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Artemisinin Combination Therapy Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Artemisinin Combination Therapy Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Artemisinin Combination Therapy Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Artemisinin Combination Therapy Status and Prospect (2014-2024)
• 1.5 Global Market Size of Artemisinin Combination Therapy (2014-2024)

2 Company Profiles

• 2.1 KPC Pharmaceuticals
  • 2.1.1 Business Overview
  • 2.1.2 Artemisinin Combination Therapy Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Denk Pharma
  • 2.2.1 Business Overview
  • 2.2.2 Artemisinin Combination Therapy Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Denk Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Desano Holdings
  • 2.3.1 Business Overview
  • 2.3.2 Artemisinin Combination Therapy Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Desano Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Shanghai Fosun Pharmaceutical Industrial Development
  • 2.4.1 Business Overview
  • 2.4.2 Artemisinin Combination Therapy Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Novartis
  • 2.5.1 Business Overview
  • 2.5.2 Artemisinin Combination Therapy Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Novartis Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Sanofi
  • 2.6.1 Business Overview
  • 2.6.2 Artemisinin Combination Therapy Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Sanofi Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Ipca Laboratories
  • 2.7.1 Business Overview
  • 2.7.2 Artemisinin Combination Therapy Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Ipca Laboratories Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Mylan
  • 2.8.1 Business Overview
  • 2.8.2 Artemisinin Combination Therapy Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Mylan Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Calyx Chemicals and Pharmaceuticals
  • 2.9.1 Business Overview
  • 2.9.2 Artemisinin Combination Therapy Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Hovid Berhad
  • 2.10.1 Business Overview
  • 2.10.2 Artemisinin Combination Therapy Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Hovid Berhad Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Cipla
  • 2.11.1 Business Overview
  • 2.11.2 Artemisinin Combination Therapy Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Cipla Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Guilin Pharmaceuticals
  • 2.12.1 Business Overview
  • 2.12.2 Artemisinin Combination Therapy Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Aspen Pharmacare Holdings
  • 2.13.1 Business Overview
  • 2.13.2 Artemisinin Combination Therapy Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Ajanta Pharma
  • 2.14.1 Business Overview
  • 2.14.2 Artemisinin Combination Therapy Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Ajanta Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2018)

3 Global Artemisinin Combination Therapy Market Competition, by Players

• 3.1 Global Artemisinin Combination Therapy Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Artemisinin Combination Therapy Players Market Share
  • 3.2.2 Top 10 Artemisinin Combination Therapy Players Market Share
• 3.3 Market Competition Trend

4 Global Artemisinin Combination Therapy Market Size by Regions

• 4.1 Global Artemisinin Combination Therapy Revenue and Market Share by Regions
• 4.2 North America Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 4.3 Europe Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 4.5 South America Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)

5 North America Artemisinin Combination Therapy Revenue by Countries

• 5.1 North America Artemisinin Combination Therapy Revenue by Countries (2014-2019)
• 5.2 USA Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 5.3 Canada Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)

6 Europe Artemisinin Combination Therapy Revenue by Countries

• 6.1 Europe Artemisinin Combination Therapy Revenue by Countries (2014-2019)
• 6.2 Germany Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 6.3 UK Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 6.4 France Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 6.5 Russia Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 6.6 Italy Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Artemisinin Combination Therapy Revenue by Countries

• 7.1 Asia-Pacific Artemisinin Combination Therapy Revenue by Countries (2014-2019)
• 7.2 China Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 7.3 Japan Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 7.4 Korea Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 7.5 India Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)

8 South America Artemisinin Combination Therapy Revenue by Countries

• 8.1 South America Artemisinin Combination Therapy Revenue by Countries (2014-2019)
• 8.2 Brazil Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Artemisinin Combination Therapy by Countries

• 9.1 Middle East and Africa Artemisinin Combination Therapy Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 9.3 UAE Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Artemisinin Combination Therapy Revenue and Growth Rate (2014-2019)

10 Global Artemisinin Combination Therapy Market Segment by Type

• 10.1 Global Artemisinin Combination Therapy Revenue and Market Share by Type (2014-2019)
• 10.2 Global Artemisinin Combination Therapy Market Forecast by Type (2019-2024)
• 10.3 Artemether+Lumefantrine Revenue Growth Rate (2014-2024)
• 10.4 Artesunate+Amodiaquine Revenue Growth Rate (2014-2024)
• 10.5 Dihydroartemisinin+Piperaquine Revenue Growth Rate (2014-2024)
• 10.6 Artesunate+Mefloquine Revenue Growth Rate (2014-2024)
• 10.7 Artesunate+Sulfadoxine-Pyrimethamine Revenue Growth Rate (2014-2024)
• 10.8 Pyronaridine-Artesunate Revenue Growth Rate (2014-2024)
• 10.9 Other Revenue Growth Rate (2014-2024)

11 Global Artemisinin Combination Therapy Market Segment by Application

• 11.1 Global Artemisinin Combination Therapy Revenue Market Share by Application (2014-2019)
• 11.2 Artemisinin Combination Therapy Market Forecast by Application (2019-2024)
• 11.3 Hospital Revenue Growth (2014-2019)
• 11.4 Clinic Revenue Growth (2014-2019)
• 11.5 Other Revenue Growth (2014-2019)

12 Global Artemisinin Combination Therapy Market Size Forecast (2019-2024)

• 12.1 Global Artemisinin Combination Therapy Market Size Forecast (2019-2024)
• 12.2 Global Artemisinin Combination Therapy Market Forecast by Regions (2019-2024)
• 12.3 North America Artemisinin Combination Therapy Revenue Market Forecast (2019-2024)
• 12.4 Europe Artemisinin Combination Therapy Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Artemisinin Combination Therapy Revenue Market Forecast (2019-2024)
• 12.6 South America Artemisinin Combination Therapy Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Artemisinin Combination Therapy Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology